16 results on '"Servente, L."'
Search Results
2. Hallazgo incidental de captación focal del colon en estudios 18 F-FDG PET/TC
- Author
-
Servente, L., primary, Gigirey, V., additional, García Fontes, M., additional, and Alonso, O., additional
- Published
- 2018
- Full Text
- View/download PDF
3. Incidental focal colonic uptake on 18 F-FDG PET/CT studies
- Author
-
Servente, L., primary, Gigirey, V., additional, García Fontes, M., additional, and Alonso, O., additional
- Published
- 2018
- Full Text
- View/download PDF
4. Patologías benignas y variantes que captan 68Ga-DOTATATE en PET/TC
- Author
-
Servente, L., primary, Bianco, C., additional, Gigirey, V., additional, and Alonso, O., additional
- Published
- 2017
- Full Text
- View/download PDF
5. PET/TC en sarcoidosis asociada a enfermedad oncológica
- Author
-
Bianco, C., primary, Servente, L., additional, Valuntas, L., additional, García Fontes, L., additional, and Engler, H., additional
- Published
- 2017
- Full Text
- View/download PDF
6. Hallazgo incidental de captación focal del colon en estudios 18F-FDG PET/TC.
- Author
-
Servente, L., Gigirey, V., García Fontes, M., and Alonso, O.
- Abstract
Resumen Objetivos Evaluar la frecuencia de la captación focal de colon como observación incidental en estudios 18 F-FDG PET/TC. Correlacionar dicho hallazgo con resultados histopatológicos. Material y métodos Se analizaron de forma sistemática 30 estudios en los que se constató captación focal del colon de un total de 3.176 PET/TC con 18 F-FDG. Se excluyeron pacientes con neoplasia colorrectal conocida. Se consignó el valor del SUV máximo (SUVm) y el hallazgo morfológico de la TC. Los estudios fueron informados por un médico radiólogo y un médico nuclear. Los hallazgos fueron correlacionados con la endoscopia y la anatomía patológica. Resultados De los 30 pacientes con lesiones focales hipermetabólicas del colon (0,94%), 15 eran hombres y 15 mujeres con edades comprendidas entre los 27 y 73 años (media 55 años). Los motivos de realización de la PET/TC fueron: cáncer broncopulmonar (4), cáncer de mama (4), tumor de origen desconocido (4), melanoma (3), carcinoma renal (3), neoplasia de cuello uterino (2), adenocarcinoma de ovario (2) y otros (8). Se realizaron 23 fibrocolonoscopias (FCC): 10 pacientes (43,4%) presentaron lesiones malignas, 6 pacientes (26,1%) lesiones premalignas y en 7 pacientes (30,4%) no se identificó ninguna lesión o esta fue benigna. En 7 pacientes no se hizo endoscopia por diversos motivos (rechazo del paciente para realizar el estudio, enfermedad oncológica avanzada). Se correlacionó con valores de SUVm y no se encontraron diferencias estadísticamente significativas entre lesiones malignas-premalignas y las lesiones benignas. Conclusiones La captación focal en colon de 18 F-FDG tiene relevancia clínica sobre todo asociada a lesión morfológica en TC, puede tratarse de un segundo tumor o una lesión premaligna. Se recomienda que todas las captaciones focales del colon sean valoradas con endoscopia, tengan o no alteraciones en TC. Objectives To assess the frequency of focal colonic uptake as an incidental observation in 18 F-FDG PET/CT studies, and to correlate this finding with histopathological results. Material and methods Out of a total of 3,176 PET/CT studies with 18 F-FDG systematic analysis was carried out on 30 studies in which colonic focal uptake was observed. Patients with known colorectal neoplasia were excluded. The maximum standardised uptake values (SUVm) and the morphological findings provided by the CT were recorded. The studies were reported by a radiologist and a nuclear medicine doctor. The findings were compared with endoscopy and pathology findings. Results Of the 30 patients with focal hypermetabolic lesions of the colon (0.94%), 15 were men and 15 were women with ages between 27 and 73 (mean 55 years). The reasons for PET/CT were bronchopulmonary cancer (4), breast cancer (4), tumour of unknown origin (4), melanoma (3), renal carcinoma (3), cervical neoplasia (2), adenocarcinoma of ovary (2), and others (8). Of the 23 colonoscopies performed, 10 patients (43.4%) had malignant lesions, 6 (26.1%) had pre-malignant lesions, and in 7 patients (30.4%) no lesion was identified or was benign. No endoscopy was performed on 7 patients for various reasons (patient refusal to perform the study, advanced oncological disease). An analysis was performed with the SUVm, with no statistically significant differences being found between malignant-premalignant lesions and benign lesions. Conclusions Focal uptake in the colon of 18 F-FDG has clinical relevance, and is mainly associated with morphological lesions in CT. It should be evaluated, as it may be a second tumour or a pre-malignant lesion. It is recommended that all focal uptakes of the colon be evaluated with endoscopy. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
7. Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States
- Author
-
Sant, Milena, Allemani, Claudia, De Angelis, Roberta, Carbone, Antonino, De SanJose, Silvia, Gianni, Alessandro M., Giraldo, Pilar, Marchesi, Francesca, Marcos-Gragera, Rafael, Martos-Jimenez, Carmen, Maynadie, Marc, Raphael, Martine, Berrino, Franco, Oberaigner, W., Storm, H. H., Aareleid, T., Jechova, M., Rousarova, M., Hakulinen, T., Hedelin, G., Tron, I., Le Gall, E., Launoy, G., MacE-Lesec'h, J., Faivre, J., Chaplain, G., Carli, P. -. M., Danzon, A., Tretarre, B., Colonna, M., Lacour, B., Raverdy, N., Berger, C., Freycon, F., Grosclaude, P., Estãve, J., Kaatsch, P., Ziegler, H., Holzel, D., Schubert Fritschle, G., Tryggvadottir, L., Berrino, F., Allemani, C., Baili, P., Ciccolallo, L., Crosignani, P., Gatta, G., Micheli, A., Sant, M., Ferretti, S., Contil, E., Ramazzotti, V., Vercelli, M., Quaglia, A., Pannelli, F., Federico, M., Artioli, M. E., Ponz De Leon, M., Benatti, P., De Lisi, V., Servente, L., Zanetti, R., Patriarca, S., Magnani, C., Pastore, G., Gafa, L., Tumino, R., Falcini, F., Budroni, M., Paci, E., Crocetti, E., Zambon, P., Guzzinati, S., Capocaccia, R., Carrani, E., De Angelis, R., Roazzi, P., Santaquilani, M., Tavilla, A., Valente, F., Verdecchia, A., Dalmas, M., Langmark, F., Andersen, A., Rachtan, J., Bielska-Lasota, M., Wronkowski, Z., Plesko, I., Obsitnikova, A., Pompe-Kirn, V., Izarzugaza, I., Martinez-Garcia, C., Garau, I., Navarro, C., Chirlaque, M. D., Ardanaz, E., Moreno, C., Galceran, J., Torrella, A., Peris-Bonet, R., Barlow, L., Moller, T., Jundt, G., Lutz, J. M., Usel, M., Coebergh, J. W. W., Van Der Does-Van Den Berg, A., Visser, O., Godward, S., Coleman, M. P., Williams, E. M. I., Forman, D., Quinn, M. J., Roche, M., Edwards, S., Stiller, C., Verne, J., Mã¸ller, H., Bell, J., Botha, J. L., Lawrence, G., Black, R., Steward, J. A., Department of Preventive and Predictive Medicine, Unit of Etiological Epidemiology and Prevention, Istituto Nazionale per lo Studio e la Cura dei Tumori, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Hospital Miguel Servet, Registre des hémopathies malignes de Côte d'Or, Laboratoire d'Hématologie, Université Paris-Sud - Paris 11 ( UP11 ) -Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Bicêtre, Department of Preventive & Predictive Medicine, Fondazione IRCCS-Istituto Nazionale dei Tumori, Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC ( CEF2P / CARCINO ), Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ), Hospital Universitario Miguel Servet, Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bicêtre, Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (EA 3181) (CEF2P / CARCINO), Université de Franche-Comté (UFC), and Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)
- Subjects
Oncology ,Cancer Research ,Survival ,Lymphoma ,MESH: Registries ,MESH : Age Distribution ,MESH : Aged ,MESH : Child, Preschool ,[ SDV.CAN ] Life Sciences [q-bio]/Cancer ,0302 clinical medicine ,MESH: Aged, 80 and over ,MESH: Lymphoma, Non-Hodgkin ,MESH : Child ,MESH: Child ,hemic and lymphatic diseases ,80 and over ,Medicine ,Registries ,Child ,Aged, 80 and over ,MESH: Aged ,MESH: Middle Aged ,MESH : Prognosis ,Relative survival ,Lymphoma, Non-Hodgkin ,EUROCARE ,Non-Hodgkin's lymphoma ,Population cancer registries ,US SEER ,Adolescent ,Adult ,Age Distribution ,Aged ,Child, Preschool ,Europe ,Feasibility Studies ,Humans ,Infant ,Middle Aged ,Prognosis ,United States ,Absolute risk reduction ,MESH : Infant ,MESH : Adult ,MESH: Infant ,3. Good health ,030220 oncology & carcinogenesis ,morphology - survival - non Hodgkin lymphoma - Europe - US ,epidemiology ,medicine.medical_specialty ,MESH : United States ,MESH : Feasibility Studies ,MESH : Europe ,Socio-culturale ,Non-Hodgkin ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,survival ,MESH: Prognosis ,cancer ,03 medical and health sciences ,Internal medicine ,MESH : Adolescent ,MESH: United States ,MESH : Lymphoma, Non-Hodgkin ,MESH : Middle Aged ,Preschool ,MESH : Aged, 80 and over ,MESH: Age Distribution ,MESH: Adolescent ,MESH: Humans ,business.industry ,MESH: Child, Preschool ,MESH : Humans ,Cancer ,MESH: Adult ,medicine.disease ,Confidence interval ,Cancer registry ,Hodgkin lymphoma ,MESH: Europe ,business ,MESH: Feasibility Studies ,MESH : Registries ,030215 immunology - Abstract
International audience; We explored the influence of morphology on geographic differences in 5-year survival for non-Hodgkin lymphoma (NHL) diagnosed in 1990-1994 and followed for 5years: 16,955 cases from 27 EUROCARE-3 cancer registries, and 22,713 cases from 9 US SEER registries. Overall 5-year relative survival was 56.1% in EUROCARE west, 47.1% in EUROCARE east and 56.3% in SEER. Relative excess risk (RER) of death was 1.05 (95% confidence interval (CI) 1.01-1.10) in EUROCARE west, 1.52 (95% CI 1.44-1.60) in EUROCARE east (SEER reference). Excess risk of death was significantly above reference (diffuse B lymphoma) for Burkitt's and NOS lymphoma; not different for lymphoblastic and other T-cell; significantly below reference (in the order of decreasing relative excess risk) for NHL NOS, mantle cell/centrocytic, lymphoplasmacytic, follicular, small lymphocytic/chronic lymphocytic leukaemia, other specified NHL and cutaneous morphologies. Interpretation of marked variation in survival with morphology is complicated by classification inconsistencies. The completeness and standardisation of cancer registry morphology data needs to be improved.
- Published
- 2008
8. Trends in cervical cancer survival in Europe, 1983-1994: a population-based study
- Author
-
Bielska-Lasota, M., Inghelmann, R., van de Poll-Franse, L., Capocaccia, R., Storm, H. H., Aareleid, T., Jechova, M., Rousarova, M., Hakulinen, T., Hedelin, G., Tron, I., Le Gall, E., Launoy, G., Mace-Lesec'h, J., Faivre, J., Chaplain, G., Carli, P. -M., Danzon, A., Tretarre, B., Colonna, M., Lacour, B., Raverdy, N., Berger, C., Freycon, B., Grosclaude, P., Esteve, J., Kaatsch, P., Ziegler, H., Holzel, D., Schubert Fritschle, G., Tryggvadottir, L., Berrino, F., Allemani, C., Baili, P., Ciccolallo, L., Crosignani, P., Gatta, G., Micheli, A., Sant, M., Taussig, E., Sowe, S., Ferretti, S., Conti, E., Vercelli, M., Quaglia, A., Pannelli, F., Federico, M., Artioli, M. E., Ponz De Leon, M., Benatti, P., De Lisi, V., Servente, L., Zanetti, R., Patriarca, S., Magnani, C., Pastore, G., Gafa, L., Tumino, R., Falcini, F., Budroni, M., Paci, E., Crocetti, E., Zambon, P., Guzzinati, S., Carrani, E., De Angelis, R., Roazzi, P., Santaquilani, M., Tavilla, A., Valente, F., Verdecchia, A., Dalmas, M., Langmark, F., Andersen, A., Pinheiro, P., Rachtan, J., Wronkowski, Z., Zwierko, M., Plesko, I., Obsitnikova, A., Pompe-Kirn, V., Primic-Zakelj, M., Izarzugaza, I., Martinez-Garcia, C., Garau, I., Navarro, C., Chirlaque, M. D., Ardanaz, E., Moreno, C., Galceran, J., Torrella, A., Peris-Bonet, R., Barlow, L., Moller, T., Jundt, G., Lutz, J. M., Bouchardy, C., Coebergh, J. W. W., van der Does-van den Berg, A., Visser, O., Godward, S., Coleman, M. P., Williams, E. M. I., Forman, D., Quinn, M. J., Roche, M., Edwards, S., Stiller, C., Verne, J., Moller, H., Bell, J., Botha, H., Lawrence, G., Black, R., Steward, J. A., Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC ( CEF2P / CARCINO ), Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ), Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (EA 3181) (CEF2P / CARCINO), Université de Franche-Comté (UFC), and Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)
- Subjects
MESH: Registries ,MESH : Mortality ,MESH : Aged ,Uterine Cervical Neoplasms ,Disease ,[ SDV.CAN ] Life Sciences [q-bio]/Cancer ,MESH: Aged, 80 and over ,0302 clinical medicine ,MESH : Female ,Registries ,MESH: Aged ,Cervical cancer ,Aged, 80 and over ,0303 health sciences ,education.field_of_study ,MESH: Middle Aged ,MESH : Prognosis ,Relative survival ,Absolute risk reduction ,Obstetrics and Gynecology ,Middle Aged ,MESH : Adult ,Prognosis ,MESH : Survival Rate ,3. Good health ,MESH: Uterine Cervical Neoplasms ,Europe ,Survival Rate ,Oncology ,030220 oncology & carcinogenesis ,Adenocarcinoma ,Female ,Adult ,medicine.medical_specialty ,MESH: Survival Rate ,Adolescent ,Population ,MESH : Uterine Cervical Neoplasms ,MESH : Europe ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,MESH: Prognosis ,Trends - cervical cancer - survival ,03 medical and health sciences ,MESH : Adolescent ,medicine ,Humans ,MESH : Middle Aged ,Mortality ,education ,MESH : Aged, 80 and over ,Survival rate ,030304 developmental biology ,Aged ,MESH: Adolescent ,Gynecology ,MESH: Humans ,MESH: Mortality ,business.industry ,MESH : Humans ,Cancer ,MESH: Adult ,Population-based study ,Survival ,Trends ,medicine.disease ,MESH: Europe ,business ,MESH: Female ,MESH : Registries ,Demography - Abstract
International audience; OBJECTIVE: To evaluate trends in survival from cervical cancer in Europe and in European countries participating in the EUROCARE study as a function of age, morphology and stage at diagnosis. METHODS: Relative survival and relative excess risk of death within 5 years of diagnosis, as a function of age, morphology and stage, among 73,022 women aged 15-99 years diagnosed during 1983-1994 and followed up to 1999 in each of 18 European countries participating in the EUROCARE study, using data from 34 population-based cancer registries. RESULTS: Overall five-year relative survival was 62%, rising by 2% during the period 1983-1994. The highest survival occurred in Northern and Western Europe and the lowest in Central Europe. Survival falls with age at diagnosis, but mainly for localised disease. Survival is higher for adenocarcinoma in younger women, but higher for squamous cell carcinoma in older women. The proportions of younger women, localised cancer and adenocarcinoma all increased. The main improvements in survival were for women under 65, and for metastatic disease. CONCLUSIONS: Survival in Europe has improved slowly but steadily, but the trend is not geographically uniform. Central European countries and the UK saw little or no improvement, and survival in those countries remains the lowest among participating countries in Europe. Further reduction of cervical cancer mortality in Europe may be expected from expansion of screening, and improvement in the treatment of older women, and of metastatic disease.
- Published
- 2007
9. Survival from rare cancer in adults: a population-based study
- Author
-
Gatta, G., Ciccolallo, L., Kunkler, I., Capocaccia, R., Berrino, F., Coleman, M. P., De Angelis, R., Faivre, J., Lutz, J. M., Martinez, C., Möller, T., Sankila, R., Oberaigner, W., Storm, H. H., Aareleid, T., Jechova, M., Rousarova, M., Hakulinen, T., Hédelin, G., Tron, I., Le Gall, E., Launoy, G., Macé Lesec'h, J., Chaplain, G., Carli, P. M., Danzon, A., Tretarre, B., Colonna, M., Lacour, B., Raverdy, N., Berger, C., Freycon, B., Grosclaude, P., Estève, J., Kaatsch, P., Ziegler, H., Hölzel, D., Schubert Fritschle, G., Tryggvadottir, L., Allemani, C., Baili, P., Crosignani, P., Micheli, A., Sant, M., Taussig, E., Sowe, S., Ferretti, S., Conti, E., Vercelli, M., Quaglia, A., Pannelli, F., Federico, Massimo, Artioli, M. E., PONZ DE LEON, Maurizio, Benatti, Piero, De Lisi, V., Servente, L., Zanetti, R., Patriarca, S., Magnani, C., Pastore, G., Gafa, L., Tumino, R., Falcini, F., Budroni, M., Paci, E., Crocetti, E., Zambon, P., Guzzinati, S., Carrani, E., Roazzi, P., Santaquilani, M., Tavilla, A., Valente, F., Verdecchia, A., Dalmas, M., Langmark, F., Andersen, A., Pinheiro, P., Rachtan, J., Bielska Lasota, M., Wronkowski, Z., Zwierko, M., Pleško, I., Obsitníkováa, A., Pompe Kirn, V., Primic Zakelj, M., Izarzugaza, I., Martinez Garcia, C., Garau, I., Navarro, C., Chirlaque, M. D., Ardanaz, E., Moreno, C., Galceran, J., Torrella, A., Peris Bonet, R., Barlow, L., Jundt, G., Bouchardy, C., Coebergh, J. W. W., van der Does van den Berg, A., Visser, O., Godward, S., Williams, E. M. I., Forman, D., Quinn, M. J., Roche, M., Edwards, S., Stiller, C., Verne, J., Møller, H., Bell, J., Botha, H., Lawrence, G., Black, R., Steward, J. A., Evaluative Epidemiology Unit, Fondazione IRCCS, Department of Preventive & Predictive Medicine, Fondazione IRCCS-Istituto Nazionale dei Tumori, Registre Bourguignon des Cancers Digestifs, Lipides - Nutrition - Cancer (U866) ( LNC ), Université de Bourgogne ( UB ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon ( ENSBANA ) -Université de Bourgogne ( UB ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon ( ENSBANA ) -Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand ( CHU Dijon ), Registre Genevois des Tumeurs, CHU Genève, Service of Preventive Medicine, Hospital Clínico San Carlos, Madrid, Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC ( CEF2P / CARCINO ), Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ), Lipides - Nutrition - Cancer (U866) (LNC), Université de Bourgogne (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon (ENSBANA)-Université de Bourgogne (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon (ENSBANA)-Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (EA 3181) (CEF2P / CARCINO), Université de Franche-Comté (UFC), and Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)
- Subjects
Male ,Oncology ,MESH : Risk ,MESH : Aged ,[ SDV.CAN ] Life Sciences [q-bio]/Cancer ,0302 clinical medicine ,Neoplasms ,Angiosarcoma ,MESH: Neoplasms ,MESH : Female ,MESH: Quality of Health Care ,MESH: Aged ,0303 health sciences ,MESH: Risk ,MESH: Middle Aged ,Relative survival ,MESH : Quality of Health Care ,Rare cancer survival ,population-based cancer study ,international comparison ,Middle Aged ,MESH : Adult ,3. Good health ,Europe ,030220 oncology & carcinogenesis ,MESH: Survival Analysis ,MESH : Rare Diseases ,Female ,Sarcoma ,Adult ,Risk ,MESH: Rare Diseases ,medicine.medical_specialty ,Adolescent ,MESH : Male ,MESH : Europe ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,03 medical and health sciences ,Rare Diseases ,Internal medicine ,MESH : Adolescent ,medicine ,Carcinoma ,Humans ,MESH : Middle Aged ,Testicular cancer ,Survival analysis ,Aged ,Quality of Health Care ,030304 developmental biology ,MESH: Adolescent ,MESH: Humans ,Uterine sarcoma ,business.industry ,MESH : Humans ,Cancer ,MESH: Adult ,medicine.disease ,Survival Analysis ,MESH : Neoplasms ,MESH: Male ,MESH: Europe ,MESH : Survival Analysis ,business ,MESH: Female - Abstract
International audience; BACKGROUND: Rare cancers are a challenge to clinical practice, and treatment experience, even in major cancer centres to which rare cancers are usually referred, is often limited. We aimed to study the epidemiology of rare cancers in a large population of several countries. METHODS: We analysed survival by age, sex, subsite, and morphology in 57,144 adults with 14 selected rare cancers diagnosed 1983-94. Variations in survival over time and between European regions were also assessed for variations in quality of care. We also estimated the adjusted relative excess risk of death for every rare cancer. FINDINGS: Overall 5-year relative survival was good (ie, >65%) for placental choriocarcinoma (85.4% [95% CI 81.4-89.5]), thyroid medullary carcinoma (72.4% [69.2-75.5]), ovarian germ-cell cancer (73.0% [70.0-76.0]), lung carcinoid (70.1% [67.3-72.9]), and cervical adenocarcinoma (65.5% [64.3-66.6]); intermediate (ie, 35-65%) for testicular cancer at age 65 years or older (64.0% [59.3-68.7]), sarcoma of extremities (60.0% [58.9-61.2]), digestive-system endocrine cancers (55.6% [54.9-56.3]), anal squamous-cell carcinoma (53.1% [51.5-54.8]), and uterine sarcoma (43.5% [42.0-44.9]); low for carcinoma of adrenal-gland cortex (32.7% [28.3-37.2]) and bladder squamous-cell carcinoma (20.4% [18.8-22.0]); and poor for angiosarcoma of liver (6.4% [1.8-11.0]) and mesothelioma (4.7% [4.3-5.2]). Survival was usually better for women than men and poor in those aged 75 years or older. Survival significantly improved over time for ovarian germ-cell cancer, sarcomas of extremities, digestive-system endocrine tumours, anal squamous-cell carcinoma, and angiosarcoma of liver. Survival in northern Europe was higher than in the other geographic groupings for most cancers. INTERPRETATION: Because effective treatments are available for several of the rare cancers we assessed, further research is needed to ascertain why survival is lower in some European countries than in others, particularly in older patients. Audit of best practice for rare cancers with treatment protocols would be useful.
- Published
- 2006
10. Preoperative fasting for the infusion of "yerba mate": a randomized clinical trial with ultrasound evaluation of gastric contents.
- Author
-
Alcarraz P, Servente L, Kuster F, Duarte L, Garau M, Desirello M, Blanc L, Bracesco N, and Perlas A
- Subjects
- Humans, Fasting, Prospective Studies, Gastrointestinal Contents, Tea, Ilex paraguariensis
- Abstract
Background: The traditional infusion of "yerba mate" is widely consumed in South America and exported to countries around the world. Although generally considered a "clear fluid", there is no data to date on the gastric emptying time of yerba mate and safe preoperative fasting intervals. The objective of this study was to evaluate the gastric emptying time of a standardized infusion of yerba mate using bedside ultrasound and compare it with the time confirm of hot and cold tea., Methods: This was a prospective, randomized crossover experimental study. Thirty healthy volunteers were evaluated after 8 hours of fasting for both fluids and solids. Gastric antral area and gastric volume were evaluated at baseline and every 20 minutes after drinking 300 mL of randomly assigned infusion of "yerba mate", hot tea, or cold tea., Results: The mean gastric emptying time was: 69.7 ± 22.1 min, 63.1 ± 14.5 min, and 64.3 ± 23.5 min for the mate, hot tea, and cold tea respectively. No significant differences were found in emptying time among the infusion groups (p-value = 0.043). When same time measures were compared, the only significant difference detected was between hot teas and mate infusion at 20 minutes (p-value = 0.012) CONCLUSION: Yerba mate infusion has a similar gastric emptying time to that of tea. All subject's gastric volume returned to baseline values by 100 minutes. It is reasonable to recommend a similar fasting period of 2 hours for mate infusion prior to elective surgery., Competing Interests: Conflicts of interest The authors declare no conflicts of interest., (Copyright © 2022 Sociedade Brasileira de Anestesiologia. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
11. [18F-fluorodesoxyglucose positron emission tomography/computed tomography in extramedullary multiple myeloma].
- Author
-
Lissarrague E, Fregeiro MS, Binstok Y, Barla C, Cavani M, Frachia F, Ranero S, Servente L, and Riva E
- Subjects
- Fluorodeoxyglucose F18, Humans, Neoplasm Recurrence, Local, Positron-Emission Tomography methods, Radiopharmaceuticals, Multiple Myeloma diagnostic imaging, Multiple Myeloma drug therapy, Positron Emission Tomography Computed Tomography methods
- Abstract
Background: 18F-fluorodesoxyglucose positron emission tomography/ computed tomography (PET-CT) has a high sensitivity and specificity to detect medullary and extramedullary lesions in multiple myeloma (MM)., Aim: To describe the findings of PET-CT in extramedullary multiple myeloma (EMM) at diagnosis and at relapse, and correlate its results with clinical variables, response to treatment and survival., Materials and Methods: Review of medical records and PET-CT reports of 39 patients with multiple myeloma (MM) who had at least one PET-CT study, treated between January 1, 2015, and January 1, 2019 at a clinical hospital., Results: The Standard Uptake Values for each hypermetabolic lesion were not described in PET-CT reports. Fifteen patients had an EMM and in eight, without a previous clinical suspicion, PET-TC lead to the diagnosis. The mortality rate in the 39 patients with MM was 46%. Sixty seven percent of deaths occurred in patients with EMM., Conclusions: PET-TC was useful to diagnose EMM. However, a standardization in PETCT reports would be required to unify criteria. As previously reported, EMM had a greater aggressiveness and lower survival.
- Published
- 2022
- Full Text
- View/download PDF
12. Quantitative comparison between single-photon emission computed tomography and positron emission tomography imaging of lung ventilation with 99m Tc-technegas and 68 Ga-gallgas in patients with chronic obstructive pulmonary disease: A pilot study.
- Author
-
Cuña EG, Gambini JP, Servente L, Savio E, Engler HW, González GA, and Alonso O
- Abstract
The aim of this study was quantitative comparison between
68 Ga-Gallgas positron emission tomography (PET) and99m Tc-Technegas single photon emission computed tomography (SPECT) for lung ventilation function assessment in patients with moderate-to-severe obstructive pulmonary disease and to identify image-derived texture features correlating to the physiologic parameters. Five patients with moderate-to-severe chronic obstructive pulmonary disease with PET and SPECT lung ventilation scans were selected for this study. Threshold-based segmentations were used to compare ventilated regions between both imaging techniques. Histograms of both scans were compared to reveal main differences in distributions of radiotracers. Volumes of segmentation as well as 50 textural features measured in the pulmonary region were correlated to the forced expiratory volume in 1 s (FEV1) as the relevant physiological variable. A better peripheral distribution of the radiotracer was observed in PET scans for three out of five patients. A segmentation threshold of 27% and 31% for normalized scans, for PET and SPECT respectively, was found optimal for volume correlation with FEV1. A high correlation (Pearson correlation coefficient >0.9) was found between 16 texture features measured from SPECT and 7 features measured from PET and FEV1. Quantitative measurements revealed different tracer distribution in both techniques. These results suggest that tracer distribution patterns may depend on the cause of the pulmonary obstruction. We found several texture features measured from SPECT to correlate to FEV1., Competing Interests: There are no conflicts of interest.- Published
- 2019
- Full Text
- View/download PDF
13. Incidental focal colonic uptake in studies 18 F-FDG PET/CT.
- Author
-
Servente L, Gigirey V, García Fontes M, and Alonso O
- Subjects
- Adult, Aged, Colon pathology, Colonic Diseases diagnostic imaging, Colonic Diseases metabolism, Colonic Neoplasms diagnostic imaging, Colonic Neoplasms metabolism, Colonoscopy, False Positive Reactions, Female, Fluorine Radioisotopes analysis, Fluorodeoxyglucose F18 analysis, Humans, Incidental Findings, Male, Middle Aged, Neoplasms diagnostic imaging, Precancerous Conditions diagnostic imaging, Precancerous Conditions metabolism, Radiopharmaceuticals analysis, Tissue Distribution, Colon metabolism, Fluorine Radioisotopes pharmacokinetics, Fluorodeoxyglucose F18 pharmacokinetics, Positron Emission Tomography Computed Tomography, Radiopharmaceuticals pharmacokinetics
- Abstract
Objectives: To assess the frequency of focal colonic uptake as an incidental observation in
18 F-FDG PET/CT studies, and to correlate this finding with histopathological results., Material and Methods: Out of a total of 3,176 PET/CT studies with18 F-FDG systematic analysis was carried out on 30 studies in which colonic focal uptake was observed. Patients with known colorectal neoplasia were excluded. The maximum standardised uptake values (SUVm) and the morphological findings provided by the CT were recorded. The studies were reported by a radiologist and a nuclear medicine doctor. The findings were compared with endoscopy and pathology findings., Results: Of the 30 patients with focal hypermetabolic lesions of the colon (0.94%), 15 were men and 15 were women with ages between 27 and 73 (mean 55 years). The reasons for PET/CT were bronchopulmonary cancer (4), breast cancer (4), tumour of unknown origin (4), melanoma (3), renal carcinoma (3), cervical neoplasia (2), adenocarcinoma of ovary (2), and others (8). Of the 23 colonoscopies performed, 10 patients (43.4%) had malignant lesions, 6 (26.1%) had pre-malignant lesions, and in 7 patients (30.4%) no lesion was identified or was benign. No endoscopy was performed on 7 patients for various reasons (patient refusal to perform the study, advanced oncological disease). An analysis was performed with the SUVm, with no statistically significant differences being found between malignant-premalignant lesions and benign lesions., Conclusions: Focal uptake in the colon of18 F-FDG has clinical relevance, and is mainly associated with morphological lesions in CT. It should be evaluated, as it may be a second tumour or a pre-malignant lesion. It is recommended that all focal uptakes of the colon be evaluated with endoscopy., (Copyright © 2017 Elsevier España, S.L.U. y SEMNIM. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
14. Determinants of quality of life in patients with cancer.
- Author
-
Dapueto JJ, Servente L, Francolino C, and Hahn EA
- Subjects
- Adolescent, Adult, Aged, Cross-Sectional Studies, Health Status, Hispanic or Latino, Humans, Middle Aged, Neoplasms pathology, Neoplasms physiopathology, Regression Analysis, Religion, Social Class, Surveys and Questionnaires, Neoplasms psychology, Quality of Life
- Abstract
Background: Because health-related quality of life (QOL) is an important outcome in cancer management, the authors sought to better understand its determinants. To address this subject, they analyzed QOL, as measured with the Functional Assessment of Cancer Therapy-General questionnaire (FACT-G), Spanish Version 4, and depicted the complex relations among physical, psychological, social, and cultural factors, including spirituality., Methods: A cross-sectional study design was used with a sample of 309 patients with cancer. The influence of several possible determinants was first studied by univariate regression analysis. Variables showing an association were included in a forward stepwise multivariate regression model., Results: Five regression models were studied, for the FACT-G total score and its four subscales. Five variables explained 32.1% of the variance of the FACT-G total score: tumor stage, spiritual well-being, income, mood disorders, and mode of questionnaire administration. The type and relevance of the explanatory variables differed among the various dimensions of QOL., Conclusions: The authors underlined the entwining of biologic, psychosocial, and spiritual factors as determinants of the QOL of patients with cancer, thus supporting the multidimensional definition and modeling of the construct., (2005 American Cancer Society.)
- Published
- 2005
- Full Text
- View/download PDF
15. Evaluation of the Functional Assessment of Cancer Therapy-General (FACT-G) Spanish Version 4 in South America: classic psychometric and item response theory analyses.
- Author
-
Dapueto JJ, Francolino C, Servente L, Chang CH, Gotta I, Levin R, and Abreu Mdel C
- Subjects
- Adult, Aged, Data Interpretation, Statistical, Female, Humans, Language, Linguistics, Male, Middle Aged, Neoplasms psychology, Psychological Theory, Reproducibility of Results, Self-Assessment, Sickness Impact Profile, Socioeconomic Factors, South Africa, Translations, Neoplasms therapy, Psychometrics instrumentation, Quality of Life psychology, Surveys and Questionnaires
- Abstract
Background: The FACT-G has gone through many validation studies. However, little research has been conducted in South American Spanish speaking patients. The present study aimed to evaluate the FACT-G Spanish Version 4 in Uruguayan cancer patients., Methods: The data analyzed were collected from 309 patients, with various tumor sites, at different stages of disease and receiving different treatments., Results: Reliability was evaluated using Cronbach's coefficient alpha and showed high internal consistency for each of the subscales and its total scale (range =.78 -.91) of the FACT-G. The FACT-G total score also showed significant mean differences among known groups (performance status, in vs. outpatients) when tested by ANOVA and t-test. When the tumor stage (Local and Regional vs. Metastatic disease) was used as a clinical anchor, the FACT-G total score, the Physical Well-being (PWB), and Functional Well-being (FWB) subscale scores showed mean differences, ranging from 5 to 10 points in a scale from 0-108 (effect sizes = 0.30-0.60). Item response theory (IRT)-based evaluation using mean square fit statistics (.60-1.4) criteria showed that only two items misfit: "Estoy satisfecho(a) con mi vida sexual" (I am satisfied with my sex life) and "Estoy satisfecho(a) de cómo estoy enfrentando mi enfermedad" (I am satisfied with how I am coping with my illness)., Conclusion: The results indicated that, using both traditional and IRT approaches, the Spanish FACT-G has good reliability and validity to be used as a QOL instrument among Uruguayan cancer patients.
- Published
- 2003
- Full Text
- View/download PDF
16. Prediction of early mortality after acute stroke.
- Author
-
Braga P, Ibarra A, Rega I, Ketzoian C, Pebet M, Servente L, and Benzano D
- Abstract
The purpose of this trial was to identify clinical factors and evaluation studies with significant value as mortality predictors in patients suffering an acute stroke. One hundred forty-eight consecutive patients hospitalized at the Hospital de Clínicas, Montevideo, with a clinical diagnosis of stroke were studied: 85 had ischemic strokes and 63 presented with intracerebral hemorrhages. The potentially predictive variables (past medical history, clinical assessment, neuroimaging, biochemical analysis) were evaluated within the first 24 hours of admission; patient follow-up was performed until they left the hospital or died. The modified National Institutes of Health Stoke Scale (NIHSS) was used to assess neurologic impairment. Three variables were identified as early mortality predictors in this population: (1) Glasgow Coma Scale score < or = 11 on admission (R = 0.19); (2) severe mass effect, defined as the presence of ventricular shift across the midline and/or enlargement of contralateral ventricle in early computed tomography (CT) scan (R = 0.26); and (3) modified NIHSS quotient score > or = 0.26 on admission (R = 0.27). We conclude that modified NIHSS was the most consistent instrument for an early identification of patients at high mortality risk, even before confirmatory evidence of the stroke's nature was obtained. A cutoff of 0.26 on NIHSS quotient score on admission was identified as the most significant predictive value.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.